🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted steps to tackle cost of living issues" in the forthcoming Budget.

During an interview with media outlets, she stated that curbing price rises is a collective task of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this year and next.

Possible Utility Cost Measures

It is understood the administration could intervene to bring down utility costs, for example by slashing the present 5% rate of value-added tax charged on energy.

An additional option is to cut some of the regulatory levies currently included in household expenses.

Budgetary Constraints and Analyst Expectations

The administration will receive the next draft from the official forecaster, the OBR, on Monday, which will clarify how much room there is for these actions.

The expectation from most analysts is that Reeves will have to announce tax rises or spending cuts in order to adhere to her self-imposed debt limits.

Earlier on Thursday, estimates showed there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the more modest range of forecasts.

"There's a shared responsibility between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor told the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While much of the focus has been on likely tax rises, the Treasury chief said the latest figures from the OBR had not altered her commitment to manifesto promises not to raise tax levels on income tax, sales tax or social security contributions.

She attributed an "unpredictable world" with growing geopolitical and commercial concerns for the Budget revenue measures, likely to be targeted on those "most able to pay."

Global Trade Tensions

Addressing apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always are paramount."

Last week's statement by Chinese authorities to increase export controls on critical minerals and other materials that are key for high-technology production led American leader the US President to suggest an further 100% import tax on imports from China, raising the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary labeled China's decision "economic coercion" and "a global supply chain power grab."

Asked about accepting the American proposal to join its dispute with China, Reeves said she was "very concerned" by China's actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the world economy and generates additional headwinds."

"In my view there are fields where we must challenge Chinese policies, but there are also important opportunities to sell into China's economy, including banking sector and other sectors of the economy. We've got to achieve that balance appropriate."

The Treasury chief also stated she was cooperating with international partners "regarding our own critical minerals plan, so that we are reduced dependence."

NHS Drug Pricing and Investment

Reeves also recognized that the cost the NHS pays for pharmaceuticals could rise as a result of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or scrapping investments in the United Kingdom, with several attributing the low prices they are getting.

Recently, the Science Minister said the price the NHS pays for medicines would need to go up to prevent businesses and pharmaceutical investment departing from the United Kingdom.

Reeves stated to the BBC: "It has been observed as a result of the cost structure, that medical research, innovative medicines have not been available in the UK in the manner that they are in other EU nations."

"Our aim is to ensure that patients getting care from the NHS are able to obtain the best life-saving treatments in the world. And so we are looking at this situation, and... looking to secure additional capital into the UK."